Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suitability of a High-energy, Low-protein Formula (Renalive® LP)

NCT06892249 is registered in ClinicalTrials.gov with Fresenius Kabi Taiwan Ltd. as lead sponsor.

NCT NCT06892249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06892249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suitability of a High-energy, Low-protein Formula (Renalive® LP)
Lead sponsor
Fresenius Kabi Taiwan Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 4, 2025
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, low protein dietary intake, malnutrition (calorie)